Lawsuit News 2026: Mass Tort, Settlement & Legal Updates
Lawsuit news changes quickly as courts issue orders, multidistrict litigation develops, settlement programs evolve and new claim-specific rulings are published. TortAdvisor Legal Insights tracks current mass tort news, settlement developments, personal injury updates, dangerous-drug litigation, medical-device cases, toxic-exposure claims, sexual-abuse litigation and other consumer legal developments, with direct links back to the appropriate evergreen research hub.
How to File a Snapchat Lawsuit 2026 If your child was sexually exploited, groomed, sextorted, or harmed on Snapchat, this guide explains How to File a Snapchat Lawsuit 2026 and what families need to know before time runs out. You may be entitled to significant compensation by filing a Snapchat lawsuit against Snap Inc. [...]
Update — 30 August 2026: A settlement has since been announced. On 15 June 2026, Pfizer and MDL leadership announced an agreement in principle to resolve eligible claims in Depo-Provera MDL 3140, before Judge M. Casey Rodgers in the U.S. District Court for the Northern District of Florida. No financial terms have been disclosed — [...]
Hire a product safety attorney to navigate CPSC compliance, recalls, and emerging risks like lithium-ion batteries. Expert guide inside.
Skip to main content 🗓 Last Updated: July 16, 2026✅ Reviewed by: TortAdvisor Editorial Team📚 Includes court, FDA, BMJ, cancer, and medical source links⚖️ Depo-Provera meningioma litigation, eligibility, and filing-deadline factors Depo-Provera Meningioma Lawsuit Guide — 2026Quick Answer: The depo provera brain tumor lawsuit involves claims that long-term use of injectable medroxyprogesterone acetate, sold [...]
Quick Answer: The talcum powder lawsuit involves claims that Johnson & Johnson's talc-based products caused ovarian cancer or mesothelioma. Settlement amounts vary widely by diagnosis severity, and eligibility generally requires documented long-term product use plus a qualifying cancer diagnosis. Johnson & Johnson's bankruptcy strategy remains unresolved as of 2026, so no global settlement has [...]
Understand delayed breast cancer diagnosis causes, risks, and how to act fast for better outcomes.
Depo-Provera MDL No. 3140 Update Depo-Provera Daubert Hearing 2026: June 24 Date, 6,000 Cases and What It Means The Depo-Provera Daubert hearing scheduled for June 24–26, 2026 is a pivotal Rule 702 hearing in the federal meningioma litigation against Pfizer and related defendants. With roughly 6,000 filed or reported claims tied to Depo-Provera and [...]
Quick Answer: The talcum powder lawsuit update for August 2026: J&J's third bankruptcy attempt was dismissed March 31, 2025, and the company has since proposed a new $5.5 billion civil settlement covering ~76,000 ovarian cancer claims (announced July 27, 2026). The federal MDL-2738 now holds ~69,000 pending cases—the largest active MDL in the country. Women [...]
Short answer: Depo-Provera (medroxyprogesterone acetate) has been linked to an elevated risk of intracranial meningioma — a type of brain tumor. Over 12,000 lawsuits have been filed against Pfizer as of 2026, consolidated into a federal MDL in the Northern District of Illinois. Women who used Depo-Provera for one year or more and later developed [...]
Injured by a defective product? Understand your product liability injury rights, claim types, and how to get compensation.
